Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response
Conclusion:CFH is implicated in nAMD patient treatment response to ranibizumab.Ophthalmologica
Source: Ophthalmologica - Category: Opthalmology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Genetics | Lucentis | Opthalmology | Ranibizumab Injection | Study